Noah tested positive for an over-the-counter supplement that is banned under the NBA's current collective bargaining agreement
"Joakim Noah of the New York Knicks has been suspended without pay for 20 games for violating the terms of the NBA/NBPA Anti-Drug Program by testing positive for Selective Androgen Receptor Modulator LGD-4033 ... Noah's' suspension will begin with the first NBA regular season or playoff game for which he is eligible and physically able to play," the NBA's statement said.
Noah, 32, has not played since Feb. 4 and underwent arthroscopic surgery on his left knee on Feb. 27 to remove a loose body. His suspension would carry into the 2017-18 season.
Noah would not have been penalized under the league's new CBA agreement that is set to begin next season, according to ESPN.
The National Basketball Players Association later announced that neither Noah nor the union would appeal the suspension.
Noah is in the first year of a four-year, $72 million free agent contract he signed last July after playing nine seasons with the Chicago Bulls. He was who drafted ninth overall in 2007.
The 6-foot-11, 230-pound Noah is averaging 5.0 points and 8.8 rebounds in 46 games (all starts) this season. For his career, he owns averages of 9.0 points and 9.4 rebounds.
- - -
Goodwin, 22, was originally signed by the Nets on March 15 and appeared in four games with averages of 9.0 points, 2.5 rebounds and 2.8 assists.
- - -
The Cleveland Cavaliers recalled guard Kay Felder from the Canton Charge of the NBA Development League.
Felder has appeared in 11 games for the Charge this season, averaging 29.9 points, 3.4 rebounds and 6.0 assists. In 37 games for the Cavs this season, Felder averaged 4.0 points. (Editing by Gene Cherry)